Media Summary: When Eric Lefkofsky's wife was diagnosed with breast cancer, it exposed how little technology and In this insightful episode of FYI, Eric Lefkofsky, CEO of xM is a portfolio of tumor-naive and tumor-informed minimal residual disease (MRD) and monitoring assays. Learn more at ...
Tempus Ai Data Driven Precision Medicine - Detailed Analysis & Overview
When Eric Lefkofsky's wife was diagnosed with breast cancer, it exposed how little technology and In this insightful episode of FYI, Eric Lefkofsky, CEO of xM is a portfolio of tumor-naive and tumor-informed minimal residual disease (MRD) and monitoring assays. Learn more at ...
